Drug treatment commissioning and market mechanisms with Alison Ritter

<p>Professor Alison Ritter talks about her recent paper <em>“Are market mechanisms associated with alcohol and other drug treatment outcomes”</em> and about the Australian context of drug treatment provision and commissioning. We discuss the challenges of measuring outcomes against commissioning structures and Professor Ritter explains how funding arrangements can end up looking like a bowl of spaghetti. Alison discusses why governments don’t necessarily have to tender competitively, about the burdens associated with the machinery of recommissioning and about the potential for fixed-price tendering to improve the quality of addiction treatment services.</p><br><p>Ritter, A., van de Ven, K., Vuong, T., Chalmers, J., Dobbins, T., Livingston, M. and Berends, L. Are market mechanisms associated with alcohol and other drug treatment outcomes?.&nbsp;<em>Addiction</em> 2021; doi:10.1111/add.15681 </p><br><p><a href="https://onlinelibrary.wiley.com/doi/10.1111/add.15681" rel="noopener noreferrer" target="_blank">https://onlinelibrary.wiley.com/doi/10.1111/add.15681</a></p><br /><hr><p style='color:grey; font-size:0.75em;'> See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.</p>